Abstract
Spinal meningiomas represent 25% to 46% of spinal neoplasms and can cause spinal cord and/or nerve compression resulting in pain, paresthesias, motor deficits, sphincter disturbances, or myelopathy. Microsurgical resection is the primary treatment option for spinal meningiomas and carries an excellent prognosis. However, patients who are not suitable for microsurgical resection, harbor multiple lesions, or lack high-grade compressive myelopathy may look to Stereotactic Radiosurgery (SRS) as another potentially efficacious tool. The role of SRS in treating intracranial tumors and malignant extracranial tumors is well established; however, little data has been reported regarding its use for benign tumors of the spine, including spinal meningiomas. This chapter evaluates the clinical efficacy of CyberKnife SRS in treating spinal meningiomas and presents the clinical outcome of relevant cohorts, complications, dosage, and indications.
| Original language | English |
|---|---|
| Title of host publication | CyberKnife Stereotactic Radiosurgery |
| Subtitle of host publication | Spine |
| Publisher | Nova Science Publishers, Inc. |
| Pages | 81-88 |
| Number of pages | 8 |
| Volume | 2 |
| ISBN (Electronic) | 9781633213395 |
| ISBN (Print) | 9781633213357 |
| State | Published - 1 Jul 2014 |
| Externally published | Yes |